Back to Screener

Healthcare

Olympus Corporation(OLYMY)

Live Price

Offline

$10.41

+4.31% today

1Y Change

-11.63%

Window

Jun 30, 2025 โ†’ Jun 26, 2026

Market Cap
$1.73T
Revenue Growth
+7.7%
EPS Growth
-48.5%
Dividend Yield
1.9%

Coverage: 249 bars ยท Jun 30, 2025 โ†’ Jun 26, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Olympus Corporation (OLYMY) is a Healthcare stock with a market cap of $1.73T and listed on OTC. The stock last traded around $10.41 and down 11.6% across the available one-year price window (Jun 30, 2025 โ†’ Jun 26, 2026). Baseline metrics include revenue growth of +7.7%, EPS growth of -48.5%, a dividend yield of 1.9%. What stands out right now is revenue +7.7%, EPS -48.5%, free cash flow 0.0% with operating margin 15.6% and ROIC 9.5%. The dividend is present but secondary, with a yield around 1.9%. Valuation is more restrained than many high-expectation growth names at P/E 20.4 and price/sales 1.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines OLYMY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

OLYMY vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

OLYMY trails SPY

OLYMY is 29.62 pts behind over the shared 1Y window.

OLYMY had 31.90 pts deeper max drawdown than SPY.

OLYMY beat SPY in 0 of 2 calendar years shown and trailed in 2.

OLYMY

-11.63%

Normalized return

SPY

+17.99%

S&P 500

Excess Return

-29.62 pts

Relative to SPY

OLYMY Max Drawdown

-41.03%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

OLYMYSPY

Calendar-Year Returns

Uses the longest available daily history for OLYMY and SPY.

YearOLYMYSPYExcessLeader
2026-17.84%+6.71%-24.54 ptsSPY
2025+7.56%+11.19%-3.64 ptsSPY

Unable to load analyst forecasts.

Timed out loading forecasts for OLYMY

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.